Acorda Blasts Bass-Backed Group's Bid To Nix Drug Patents
Acorda Therapeutics Inc. fought back Monday against a bid by a group with close ties to hedge fund manager Kyle Bass to invalidate four of its patents related to its multiple...To view the full article, register now.
Already a subscriber? Click here to view full article